ArticleFrontiers in endocrinology2026
Global, regional and national burden of polycystic ovary syndrome: historical trends from 1990 to 2021 and projections to 2035.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to deepen the understanding and assessment of the global burden of polycystic ovary syndrome (PCOS), providing a basis for policy-making and resource allocation to help achieve global health goals. Methods: This study focused on analyzing the disease burden of PCOS at the global, regional, and national levels, considering age factors and predicting trends up to 2035. This study also involved cross-national inequality analysis, frontier analysis, and decomposition analysis. Results: The burden of PCOS is increasing, with the age of onset concentrated in the 10-19 age group, while the number of cases and DALYs is predominantly in the 15-49 age group. Countries with a higher Socio-demographic Index (SDI) bear a heavier burden of PCOS, effectively controlling its growth trend. Inequality persists. Population growth and epidemiological changes are driving the increase in the burden of PCOS. By 2035, the burden of PCOS is projected to continue increasing. Conclusion: The global burden of PCOS shows an overall increasing trend, with significant differences among different regions and countries. Greater support is needed for low SDI to standardize diagnostic criteria, raise public health awareness, and better protect women's health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.